SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
4	Statement of changes in beneficial ownership of securities	Jul 12, 2023	View HTML 0001562180-23-005880.pdf 0001562180-23-005880.rtf 0001562180-23-005880.xls
8-K	Report of unscheduled material events or corporate event	Jul 27, 2023	View HTML 0000950170-23-035133.pdf 0000950170-23-035133.rtf 0000950170-23-035133.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
8-K	Report of unscheduled material events or corporate event	Aug 02, 2023	View HTML 0000950170-23-036770.pdf 0000950170-23-036770.rtf 0000950170-23-036770.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
10-Q	Quarterly report which provides a continuing view of a company's financial position	Aug 04, 2023	View HTML 0000950170-23-038514.pdf 0000950170-23-038514.rtf 0000950170-23-038514.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	Aug 22, 2023	View HTML 0001969223-23-000316.pdf 0001969223-23-000316.rtf 0001969223-23-000316.xls
144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	Aug 22, 2023	View HTML 0001969223-23-000317.pdf 0001969223-23-000317.rtf 0001969223-23-000317.xls
4	Statement of changes in beneficial ownership of securities	Aug 24, 2023	View HTML 0000899243-23-018380.pdf 0000899243-23-018380.rtf 0000899243-23-018380.xls
4	Statement of changes in beneficial ownership of securities	Aug 28, 2023	View HTML 0000950170-23-044843.pdf 0000950170-23-044843.rtf 0000950170-23-044843.xls
SC 13D/A	An amendment to a SC 13D filing	Aug 30, 2023	View HTML 0001193125-23-225037.pdf 0001193125-23-225037.rtf 0001193125-23-225037.xls
4/A	Amendment to a previously filed 4	Aug 30, 2023	View HTML 0000899243-23-018606.pdf 0000899243-23-018606.rtf 0000899243-23-018606.xls

Data provided by Kaleidoscope.